Credit Suisse Initiates On Smid-Cap Biotechs, Reveals Favorite Stock Picks

In a new report, Credit Suisse analyst Kennen MacKay discussed the firm’s top biotech stock picks. According to MacKay, it’s important for investors to remain selective, as the biotech sector undergoes a market correction.

Credit Suisse focused on four themes when identifying top biotech picks:

  • 1. Potential near-term positive clinical catalysts
  • 2. Potential near-term product launches
  • 3. Solid management teams
  • 4. Solid biology supporting underlying technology

Overall, the firm sees…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and is always available on your local internet!